$0.16 EPS Expected for SLM (SLM), First Light Asset Management Has Trimmed By $402,969 Its Aratana Therapeutics (PETX) Position

June 20, 2017 - By marketbeat

First Light Asset Management Llc decreased Aratana Therapeutics Inc (PETX) stake by 12.31% reported in 2016Q4 SEC filing. First Light Asset Management Llc sold 57,567 shares as Aratana Therapeutics Inc (PETX)’s stock declined 5.36%. The First Light Asset Management Llc holds 410,176 shares with $2.95M value, down from 467,743 last quarter. Aratana Therapeutics Inc now has $290.66 million valuation. The stock increased 5.44% or $0.35 during the last trading session, reaching $6.78. About shares traded. Aratana Therapeutics Inc (NASDAQ:PETX) has risen 1.52% since June 20, 2016 and is uptrending. It has underperformed by 15.18% the S&P500.

Analysts expect SLM Corp (NASDAQ:SLM) to report $0.16 EPS on July, 19.They anticipate $0.04 EPS change or 33.33% from last quarter’s $0.12 EPS. SLM’s profit would be $68.36 million giving it 16.86 P/E if the $0.16 EPS is correct. After having $0.21 EPS previously, SLM Corp’s analysts see -23.81% EPS growth. The stock increased 2.86% or $0.3 during the last trading session, reaching $10.79. About shares traded. SLM Corp (NASDAQ:SLM) has risen 78.01% since June 20, 2016 and is uptrending. It has outperformed by 61.31% the S&P500.

SLM Corporation is a holding company. The company has market cap of $4.61 billion. The Company’s primary business is to originate and service loans it makes to students and their families to finance the cost of their education. It has a 18.23 P/E ratio. The Firm is a saving, planning and paying for college company.

Investors sentiment decreased to 1.07 in 2016 Q4. Its down 0.09, from 1.16 in 2016Q3. It fall, as 22 investors sold SLM Corp shares while 96 reduced holdings. 50 funds opened positions while 76 raised stakes. 418.95 million shares or 0.48% less from 420.96 million shares in 2016Q3 were reported. Carroll Financial Assoc Incorporated stated it has 0% of its portfolio in SLM Corp (NASDAQ:SLM). Bnp Paribas Arbitrage Sa owns 165,179 shares. Ubs Oconnor Limited Liability invested in 0% or 64,808 shares. Virginia Retirement Et Al holds 0.01% in SLM Corp (NASDAQ:SLM) or 96,100 shares. Utah Retirement Sys accumulated 77,582 shares. Tci Wealth Advisors Inc, a Arizona-based fund reported 179 shares. Blackrock Ltd reported 2.55M shares or 0.01% of all its holdings. 283,500 are owned by Renaissance Technology Ltd Liability. Park National Corp Oh has 0.01% invested in SLM Corp (NASDAQ:SLM). New York State Teachers Retirement accumulated 819,514 shares. Moreover, Ngam Advsrs Lp has 0.01% invested in SLM Corp (NASDAQ:SLM). Brown Advisory invested in 24,510 shares. Gemmer Asset Management Ltd Liability Corp stated it has 0% of its portfolio in SLM Corp (NASDAQ:SLM). The Wisconsin-based Northwestern Mutual Wealth Commerce has invested 0% in SLM Corp (NASDAQ:SLM). Johnson Fin Inc invested 0% in SLM Corp (NASDAQ:SLM).

Among 9 analysts covering Sallie Mae (NASDAQ:SLM), 8 have Buy rating, 0 Sell and 1 Hold. Therefore 89% are positive. Sallie Mae had 11 analyst reports since October 12, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Tuesday, January 31 by Wedbush. The stock has “Buy” rating by Jefferies on Wednesday, December 7. The rating was upgraded by Goldman Sachs on Wednesday, January 13 to “Buy”. The rating was initiated by FBR Capital with “Outperform” on Friday, December 2. The firm earned “Buy” rating on Thursday, January 21 by Compass Point. The stock of SLM Corp (NASDAQ:SLM) has “Buy” rating given on Tuesday, May 30 by Credit Suisse. The rating was maintained by Goldman Sachs with “Buy” on Wednesday, August 10. The firm has “Hold” rating by BMO Capital Markets given on Wednesday, May 31. The stock of SLM Corp (NASDAQ:SLM) earned “Overweight” rating by JP Morgan on Monday, November 30. Compass Point maintained the shares of SLM in report on Monday, October 12 with “Buy” rating.

Since March 1, 2017, it had 0 buys, and 2 sales for $338,495 activity. Thome Paul F also sold $112,605 worth of SLM Corp (NASDAQ:SLM) on Wednesday, March 1.

Among 6 analysts covering Aratana Therapeutics (NASDAQ:PETX), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Aratana Therapeutics had 9 analyst reports since July 29, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Aratana Therapeutics Inc (NASDAQ:PETX) rating on Wednesday, March 16. Stifel Nicolaus has “Buy” rating and $11 target. The firm earned “Overweight” rating on Thursday, August 11 by Barclays Capital. The stock has “Hold” rating by Craig Hallum on Friday, September 25. Lake Street initiated Aratana Therapeutics Inc (NASDAQ:PETX) rating on Wednesday, July 29. Lake Street has “Buy” rating and $28 target. The stock has “Buy” rating by Jefferies on Friday, August 19. The firm has “Outperform” rating given on Thursday, February 4 by Credit Suisse.

Since January 27, 2017, it had 0 insider purchases, and 1 insider sale for $385,875 activity. St Peter Steven sold $385,875 worth of Aratana Therapeutics Inc (NASDAQ:PETX) on Friday, January 27.

Investors sentiment decreased to 0.71 in Q4 2016. Its down 1.48, from 2.19 in 2016Q3. It turned negative, as 25 investors sold PETX shares while 37 reduced holdings. 12 funds opened positions while 32 raised stakes. 28.38 million shares or 0.36% less from 28.48 million shares in 2016Q3 were reported. Acadian Asset Management Ltd Co reported 501,166 shares stake. Royal State Bank Of Canada owns 746 shares or 0% of their US portfolio. Tfs Ltd Liability holds 0.1% or 53,001 shares in its portfolio. Ny State Common Retirement Fund reported 38,700 shares. Jennison Associate Limited Liability Company invested in 0.01% or 1.15M shares. 129,659 are owned by National Bank & Trust Of Ny Mellon. 250,000 were reported by Mpm Asset. Amer Century Companies invested 0% in Aratana Therapeutics Inc (NASDAQ:PETX). Ubs Asset Americas stated it has 2,079 shares or 0% of all its holdings. Credit Suisse Ag holds 0% of its portfolio in Aratana Therapeutics Inc (NASDAQ:PETX) for 25,310 shares. Amer Int Group Inc holds 0% in Aratana Therapeutics Inc (NASDAQ:PETX) or 19,180 shares. Tocqueville Asset Management Limited Partnership stated it has 160,000 shares. Dimensional Fund Advisors Limited Partnership owns 69,059 shares or 0% of their US portfolio. Pnc Finance Svcs Inc accumulated 0% or 1,600 shares. State Street holds 653,272 shares.

First Light Asset Management Llc increased Veracyte Inc (NASDAQ:VCYT) stake by 118,431 shares to 692,210 valued at $5.36 million in 2016Q4. It also upped Bio Techne Corp (NASDAQ:TECH) stake by 14,764 shares and now owns 38,502 shares. Neogenomics Inc (NASDAQ:NEO) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: